ARMISTICE CAPITAL, LLC
Q2 2022 13F-HR Holdings
Net value change ($000)
+560,811
(10.8%)
New positions
71
Sold out positions
39
Turnover %
59.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| SPY | 1,263,788 | NEW |
| IWM | 567,356 | NEW |
| ORLY | 91,972 | NEW |
| DG | 75,631 | NEW |
| NBIX | 68,126 | 111.8% |
| LULU | 62,311 | NEW |
| REGN | 52,465 | 89.4% |
| TSCO | 51,802 | NEW |
| JNJ | 45,443 | NEW |
| KYNB | 43,212 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| HD | -104,735 | -100.0% |
| BIIB | -72,333 | -60.0% |
| TGT | -68,271 | -100.0% |
| Biohaven Pharmaceutical Holding Co Ltd. | -62,131 | -100.0% |
| Ortho Clinical Diagnostics Holdings plc | -62,026 | -100.0% |
| VTRS | -57,869 | -91.7% |
| FIVE | -57,290 | -100.0% |
| AZO | -45,964 | -100.0% |
| JAZZ | -30,105 | -41.0% |
| GOOGL | -26,465 | -63.4% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|